Holen Sie sich die Stockscreener-App
0.7664
0.56%
0.0043
Finanzdaten der Connect Biopharma Holdings Ltd-Aktie (CNTB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1,538%
2.768
|
0.169 | - | 0.016 | 0.048 |
| Operating Expenses |
3.01%
20.37
|
19.78 | 15.53 | 17.69 | 13.47 |
| Operating Income/Loss |
10.22%
-17.60
|
-19.61 | -15.53 | -17.68 | -13.42 |
| Nonoperating Income/Loss |
47.86%
0.38
|
0.257 | 0.444 | 0.538 | 0.58 |
| Income/Loss From Continuing Operations Before Tax |
10.99%
-17.22
|
-19.35 | -15.08 | -17.14 | -12.90 |
| Income Tax Expense/Benefit |
25.00%
0.06
|
0.048 | 0.027 | 0.061 | 0.055 |
| Net Income/Loss |
10.90%
-17.28
|
-19.40 | -15.11 | -17.20 | -12.90 |
| Basic Average Shares |
11.21%
62.88
|
56.55 | - | 55.72 | 55.50 |
| Diluted Average Shares |
11.21%
62.88
|
56.55 | - | 55.72 | 55.50 |
| Basic Earnings Per Share |
20.59%
-0.27
|
-0.34 | - | -0.31 | -0.23 |
| Diluted Earnings Per Share |
20.59%
-0.27
|
-0.34 | - | -0.31 | -0.23 |
2.90%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):